Incannex Healthcare (IXHL) Competitors $0.15 -0.46 (-75.10%) Closing price 04/29/2025 04:00 PM EasternExtended Trading$0.15 0.00 (-1.91%) As of 04/29/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IXHL vs. CNTB, MRSN, SPRO, TNYA, OKYO, RNTX, ANEB, AADI, APLT, and BLUEShould you be buying Incannex Healthcare stock or one of its competitors? The main competitors of Incannex Healthcare include Connect Biopharma (CNTB), Mersana Therapeutics (MRSN), Spero Therapeutics (SPRO), Tenaya Therapeutics (TNYA), OKYO Pharma (OKYO), Rein Therapeutics (RNTX), Anebulo Pharmaceuticals (ANEB), Aadi Bioscience (AADI), Applied Therapeutics (APLT), and bluebird bio (BLUE). These companies are all part of the "pharmaceutical products" industry. Incannex Healthcare vs. Connect Biopharma Mersana Therapeutics Spero Therapeutics Tenaya Therapeutics OKYO Pharma Rein Therapeutics Anebulo Pharmaceuticals Aadi Bioscience Applied Therapeutics bluebird bio Incannex Healthcare (NASDAQ:IXHL) and Connect Biopharma (NASDAQ:CNTB) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, community ranking, analyst recommendations, media sentiment, dividends, valuation, risk, profitability and institutional ownership. Do analysts rate IXHL or CNTB? Connect Biopharma has a consensus price target of $8.00, suggesting a potential upside of 887.65%. Given Connect Biopharma's stronger consensus rating and higher possible upside, analysts plainly believe Connect Biopharma is more favorable than Incannex Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Incannex Healthcare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Connect Biopharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, IXHL or CNTB? Incannex Healthcare has a beta of 7.54, suggesting that its share price is 654% more volatile than the S&P 500. Comparatively, Connect Biopharma has a beta of -0.22, suggesting that its share price is 122% less volatile than the S&P 500. Which has preferable earnings & valuation, IXHL or CNTB? Incannex Healthcare has higher earnings, but lower revenue than Connect Biopharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIncannex Healthcare$98K27.68-$18.46M-$1.39-0.11Connect Biopharma$24.12M1.86-$59.50MN/AN/A Is IXHL or CNTB more profitable? Connect Biopharma's return on equity of 0.00% beat Incannex Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Incannex HealthcareN/A -289.30% -154.96% Connect Biopharma N/A N/A N/A Does the MarketBeat Community favor IXHL or CNTB? Connect Biopharma received 19 more outperform votes than Incannex Healthcare when rated by MarketBeat users. CompanyUnderperformOutperformIncannex HealthcareN/AN/AConnect BiopharmaOutperform Votes1973.08% Underperform Votes726.92% Does the media prefer IXHL or CNTB? In the previous week, Connect Biopharma had 1 more articles in the media than Incannex Healthcare. MarketBeat recorded 3 mentions for Connect Biopharma and 2 mentions for Incannex Healthcare. Incannex Healthcare's average media sentiment score of 0.44 beat Connect Biopharma's score of 0.30 indicating that Incannex Healthcare is being referred to more favorably in the media. Company Overall Sentiment Incannex Healthcare Neutral Connect Biopharma Neutral Do institutionals & insiders believe in IXHL or CNTB? 0.4% of Incannex Healthcare shares are held by institutional investors. Comparatively, 58.7% of Connect Biopharma shares are held by institutional investors. 26.5% of Incannex Healthcare shares are held by company insiders. Comparatively, 22.6% of Connect Biopharma shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryConnect Biopharma beats Incannex Healthcare on 9 of the 14 factors compared between the two stocks. Get Incannex Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for IXHL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IXHL vs. The Competition Export to ExcelMetricIncannex HealthcarePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.71M$6.79B$5.51B$7.84BDividend YieldN/A3.10%5.11%4.23%P/E Ratio-0.117.3322.4018.52Price / Sales27.68240.73399.74103.35Price / CashN/A65.8538.1834.62Price / Book3.046.396.744.24Net Income-$18.46M$142.94M$3.22B$248.05M7 Day Performance-72.92%4.50%4.33%5.03%1 Month Performance-78.61%-1.61%-0.82%1.69%1 Year Performance-93.97%-2.44%16.67%4.20% Incannex Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IXHLIncannex Healthcare0.6494 of 5 stars$0.15-75.1%N/A-94.0%$2.71M$98,000.00-0.113Short Interest ↑High Trading VolumeCNTBConnect Biopharma2.6108 of 5 stars$0.75+0.8%$8.00+973.8%-39.1%$41.24M$24.12M0.00110Short Interest ↑MRSNMersana Therapeutics3.7923 of 5 stars$0.33-7.8%$4.00+1,123.6%-88.3%$40.74M$40.50M-0.54150Gap DownSPROSpero Therapeutics4.326 of 5 stars$0.73-3.9%$5.00+589.7%-53.4%$40.53M$27.40M10.36150Short Interest ↑News CoverageTNYATenaya Therapeutics3.7895 of 5 stars$0.46+1.8%$6.25+1,264.0%-89.4%$40.13MN/A-0.32110Short Interest ↓OKYOOKYO Pharma2.8896 of 5 stars$1.17-4.1%$7.00+498.3%+8.5%$39.59MN/A0.007Short Interest ↓RNTXRein TherapeuticsN/A$1.78+4.7%N/AN/A$39.15MN/A-0.579Gap DownANEBAnebulo Pharmaceuticals2.0061 of 5 stars$0.95-5.9%$8.00+742.1%-57.9%$39.03MN/A-3.394Short Interest ↑AADIAadi BioscienceN/A$1.57+1.9%$1.67+6.2%-20.4%$38.77M$25.07M-0.6940Upcoming EarningsAPLTApplied Therapeutics4.0888 of 5 stars$0.33-0.1%$6.10+1,734.0%-90.9%$38.70M$455,000.00-0.2130News CoveragePositive NewsBLUEbluebird bio3.0103 of 5 stars$3.90-5.8%$44.60+1,043.6%-77.7%$38.18M$83.81M-0.10520Analyst ForecastShort Interest ↓ Related Companies and Tools Related Companies Connect Biopharma Alternatives Mersana Therapeutics Alternatives Spero Therapeutics Alternatives Tenaya Therapeutics Alternatives OKYO Pharma Alternatives Rein Therapeutics Alternatives Anebulo Pharmaceuticals Alternatives Aadi Bioscience Alternatives Applied Therapeutics Alternatives bluebird bio Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IXHL) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe Silent Heist Draining Your Retirement SavingsU.S. Debt Crisis - A Silent Heist of Your Retirement Savings Americans are losing wealth daily and don't ev...American Hartford Gold | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incannex Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Incannex Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IXHL Stock Free IXHL Stock Alerts